DOV CHARLES GOLDENBERG

(Fonte: Lattes)
Índice h a partir de 2011
7
Lattes
ORCID
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/04 - Laboratório de Microcirurgia, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

search.filters.applied.f.dateIssued: 2012 ×

Resultados de Busca

Agora exibindo 1 - 2 de 2
  • article
    Resultados da ressecção de hemangiomas infantis nasais em fase proliferativa: abordagem segura para os tumores centrais da face
    (2012) GOLDENBERG, Dov Charles; FERNANDES, Thadeu Rezende Rangel; HIRAKI, Patricia Yuko; SMANIOTTO, Pedro Henrique de Souza; MOURA, Tatiana de; FERREIRA, Marcus Castro
    BACKGROUND: Infantile hemangioma is the most common benign tumor in infancy and occurs most often in the cervicofacial region. Its course can be divided into 3 phases with frequent spontaneous regression. However, residual sequelae or anatomical structure deformities can occur. An early and definitive surgical approach aiming at good aesthetic results and anatomical preservation is indicated in such cases because of the localization of the nasal hemangiomas and their capacity to disfigure. This study analyzed the results of the definitive surgical approach for proliferative nasal hemangiomas according to an objective evaluation. METHODS: From 1997 to 2009, 20 patients suffering from nasal hemangiomas in the proliferative phase were treated surgically. The lesions were analysed according to the area affected and type of treatment. Complication rates and the need for additional procedures were analyzed. The aesthetic results were evaluated by independent evaluators. RESULTS: The lesions were localized in the tip of the nose in 50% of patients, dorsal area in 20%, all subunits in 15%, paranasal areas in 10%, and alar area in 5%. Resection was total and subtotal in 60% and 40% of the patients, respectively. The mean follow-up period was 42.6 months. The mean number of surgical procedures per patient was 1.3 ± 0.7. No significant complications were observed. The results were positively evaluated with respect to the reduction of lesion volume and improved face shape, corroborating the proposed approach. CONCLUSIONS: Definitive surgical treatment is a safe and effective alternative for the management of nasal hemangiomas and has low complication rates.
  • article
    Idade e indicações de osteotomias para avanço frontofacial em pacientes com craniossinostoses sindrômicas
    (2012) ALONSO, Nivaldo; MATUSHITA, Hamilton; GOLDENBERG, Dov Charles; BASTOS, Endrigo Oliveira
    BACKGROUND: Craniofacial surgery has overcome many challenges since its initiation into clinical practice. Several technical issues have been addressed and the basic infrastructure of the specialty has now been developed. At present, 25 years after the first publications on frontofacial advancement, questions still remain as to the appropriate age for surgery and the appropriate type of surgery that should be performed. The aim of this study was to evaluate patients surgically treated for syndromic craniosynostosis over the last 10 years at our institution. METHODS: All syndromic patients who underwent monobloc frontofacial advancement or only isolated facial advancement from 2001 to 2011were selected. Out of 70 patients in total, 56 underwent monobloc frontofacial advancement and 14 underwent facial advancement after fronto-orbital remodeling. All data concerning these patients were correlated with patient age and final result. Moreover, age at surgery, complications, and final results were correlated with the main preexisting problems. RESULTS: Final results for syndromic patients varied, depending on the syndrome and the age at which the procedure was performed. Monobloc frontofacial advancements had a low index of immediate postoperative complications, but there was a clear need for further procedures at the time of final facial growth. The index of positive outcome was higher in patients who underwent surgery at an older age. CONCLUSIONS: In cases of severe craniosynostosis with functional problems, monobloc frontofacial advancement is still the best therapeutic option.